Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 6Dermatologic 2Sarcoma 1Lymphoid 1Gastrointestinal 1

Conditions

Carcinoma, Basal Cell 11Skin Neoplasms 4Basal Cell Nevus Syndrome 4Neoplasms, Basal Cell 2Medulloblastoma 2Squamous Cell Carcinoma of Head and Neck 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Hematologic Neoplasms 1Eyelid Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

sonidegib 2Etoposide 2Carboplatin 2tipifarnib 1merphos 1entinostat 1carboxyamido-triazole 1bempegaldesleukin 1Vincristine 1Thrombopoietin 1Thalidomide 1Paclitaxel 1Oxaliplatin 1Nivolumab 1NVP-LEQ506 1Methotrexate 1Mental Status and Dementia Tests 1LY2940680 1Irinotecan 1Immunologic Techniques 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Fentanyl 1Docetaxel 1Cyclophosphamide 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Medulloblastoma × sonidegib × Dermatologic × Clear all
NCT00880308 2020-12-19

Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors

Novartis

Phase 1 Completed
103 enrolled
CNSDermatologic

Carcinoma, Basal Cell, Medulloblastoma

NCT01208831 2020-12-19

An East Asian Study of LDE225

Novartis

Phase 1 Completed
45 enrolled
CNSDermatologic

Carcinoma, Basal Cell, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡